An article originating from research in Garry Buettner's laboratory in the Free Radical and Radiation Biology (FRRBP) program describes the mechanism of ascorbate (Vitamin C) in selectively killing cancer cells. Published in Redox Biology this adds to the body of literature supporting the efficacy of this cancer therapy. The announcement may be read here.